Clinical trial / 2006
Resveratrol improved aerobic capacity and protected mice from diet-induced obesity and insulin resistance, while human Sirt1 SNPs linked to energy homeostasis.
Mice were treated with resveratrol to evaluate its effects on mitochondrial function and metabolic homeostasis, alongside an analysis of SIRT1 genetics in humans. Resveratrol treatment significantly increased aerobic capacity in mice, evidenced by higher running time and oxygen consumption in muscle fibers, and protected against diet-induced obesity and insulin resistance. The effects were associated with induction of genes for oxidative phosphorylation and mitochondrial biogenesis via PGC-1alpha and SIRT1 activation. Additionally, three Sirt1 SNPs were associated with energy homeostasis in Finnish subjects.
- Study type
- Controlled animal experiment and human genetic association study
- Who was studied
- Mice and Finnish subjects
- What was measured
- Aerobic capacity, oxygen consumption, diet-induced obesity, insulin resistance, and Sirt1 SNPs with energy homeostasis
THE PAPER
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Cell, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.